Latest return on equity
BioMarin Pharmaceutical Return on equity
Direct answer
BioMarin Pharmaceutical's return on equity is 1.18%.
The verified market snapshot reports 1.18%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free BioMarin Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- 1.18%
Explore related company data
View BioMarin Pharmaceutical's market capitalizationView BioMarin Pharmaceutical's p/e ratioView BioMarin Pharmaceutical's price-to-book ratioView BioMarin Pharmaceutical's dividend yieldView BioMarin Pharmaceutical's 52-week price rangeView BioMarin Pharmaceutical's revenue growthView BioMarin Pharmaceutical's profit marginView BioMarin Pharmaceutical's debt-to-equity ratioView all BioMarin Pharmaceutical key metricsReturn to BioMarin Pharmaceutical profile